World Health Organization (WHO) conducted a large, open-label, randomised-controlled trial involving hospital inpatients to evaluate the effects of remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a on mortality caused by Covid-19. Th...
China Has Begun the Monoclonal Neutralising Antibody Phase 1 Clinical Trial against COVID-19 China has begun the recombinant fully human monoclonal neutralising antibody (JS016) phase 1 clinical trial against COVID-19 in Shanghai on 7 June 2020 afte...
In order to combat the current outbreak of pneumonia caused by a novel coronavirus (nCoV) reported in Wuhan, China, Chinese scientists select 30 medications including traditional Chinese medicines as candidates against nCoV 1 . In particular, an ant...
The outbreak of atypical pneumonia caused by novel coronavirus (COVID-19) in Wuhan, China is still ongoing and has spread to other regions in China and overseas. It has been reported that the estimated basic reproductive number (Ro) of COVID-19 repo...
The outbreak of atypical pneumonia caused by novel coronavirus (COVID-19) in Wuhan, China is still ongoing. As of 19-March, 2020, there have been more than 80,928 confirmed cases of infections and 3,245 deaths in mainland China. Besides, there are 7...
Suspension of Antiviral Treatment for Alleviating Drug Resistance during Influenza Pandemics Antiviral stockpiling is one of the actions taken by many countries and the World Health Organization (WHO) for preparation of the next influenza pandemic. ...
